Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies
Published 2020 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Interplay of EMT and CSC in Cancer and the Potential Therapeutic Strategies
Authors
Keywords
-
Journal
Frontiers in Pharmacology
Volume 11, Issue -, Pages -
Publisher
Frontiers Media SA
Online
2020-06-17
DOI
10.3389/fphar.2020.00904
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Recent Advances in Cancer Stem Cell-Targeted Immunotherapy
- (2019) Narayanasamy Badrinath et al. Cancers
- Development of a Non-Coding-RNA-based EMT/CSC Inhibitory Nanomedicine for In Vivo Treatment and Monitoring of HCC
- (2019) Ruomi Guo et al. Advanced Science
- EMT is associated with an epigenetic signature of ECM remodeling genes
- (2019) Paul Peixoto et al. Cell Death & Disease
- Monitoring of cancer patients via next‐generation sequencing of patient‐derived circulating tumor cells and tumor DNA
- (2019) Kaoru Onidani et al. CANCER SCIENCE
- The Role of Epithelial-to-Mesenchymal Plasticity in Ovarian Cancer Progression and Therapy Resistance
- (2019) Nele Loret et al. Cancers
- Next-generation nanotheranostics targeting cancer stem cells
- (2019) Asmaa Reda et al. Nanomedicine
- Block Copolymer Micelles in Nanomedicine Applications
- (2018) Horacio Cabral et al. CHEMICAL REVIEWS
- Nanomedicine: An effective tool in cancer therapy
- (2018) Saima Aftab et al. INTERNATIONAL JOURNAL OF PHARMACEUTICS
- Targeting cancer stem cells in the clinic: Current status and perspectives
- (2018) Stephanie Annett et al. PHARMACOLOGY & THERAPEUTICS
- Seek and destroy: improving PK/PD profiles of anticancer agents with nanoparticles
- (2018) Anne Rodallec et al. Expert Review of Clinical Pharmacology
- MiR-361-3p regulates ERK1/2-induced EMT via DUSP2 mRNA degradation in pancreatic ductal adenocarcinoma
- (2018) Jisheng Hu et al. Cell Death & Disease
- Targeting Cancer Stemness in the Clinic: From Hype to Hope
- (2018) Caner Saygin et al. Cell Stem Cell
- Epithelial-Mesenchymal Transition and Metastasis under the Control of Transforming Growth Factor β
- (2018) Yutaro Tsubakihara et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- miRBase: from microRNA sequences to function
- (2018) Ana Kozomara et al. NUCLEIC ACIDS RESEARCH
- Therapy resistance mediated by cancer stem cells
- (2018) Teresa Bernadette Steinbichler et al. SEMINARS IN CANCER BIOLOGY
- EpCAMhigh and EpCAMlow circulating tumor cells in metastatic prostate and breast cancer patients
- (2018) Sanne de Wit et al. Oncotarget
- Concise Reviews: Cancer Stem Cell Targeted Therapies: Toward Clinical Success
- (2018) Amar Desai et al. Stem Cells Translational Medicine
- Cabazitaxel and silibinin co-encapsulated cationic liposomes for CD44 targeted delivery: A new insight into nanomedicine based combinational chemotherapy for prostate cancer
- (2018) Shaheen Mahira et al. BIOMEDICINE & PHARMACOTHERAPY
- Reprogramming acute myeloid leukemia into sensitivity for retinoic-acid-driven differentiation
- (2017) Noortje van Gils et al. EXPERIMENTAL HEMATOLOGY
- ABC Transporters in Cancer Stem Cells: Beyond Chemoresistance
- (2017) Romana-Rea Begicevic et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Integrated analysis identifies microRNA-195 as a suppressor of Hippo-YAP pathway in colorectal cancer
- (2017) Min Sun et al. Journal of Hematology & Oncology
- The EMT-activator Zeb1 is a key factor for cell plasticity and promotes metastasis in pancreatic cancer
- (2017) Angela M. Krebs et al. NATURE CELL BIOLOGY
- EMT, CSCs, and drug resistance: the mechanistic link and clinical implications
- (2017) Tsukasa Shibue et al. Nature Reviews Clinical Oncology
- Epithelial-mesenchymal transition in prostate cancer: an overview
- (2017) Micaela Montanari et al. Oncotarget
- Combination therapy in combating cancer
- (2017) Reza Bayat Mokhtari et al. Oncotarget
- The Human Cell Atlas
- (2017) Aviv Regev et al. eLife
- Targeting Signaling Pathways in Cancer Stem Cells for Cancer Treatment
- (2017) Jeffrey Koury et al. Stem Cells International
- Tumor-associated macrophages remodeling EMT and predicting survival in colorectal carcinoma
- (2017) Si Li et al. OncoImmunology
- Transcription Factor Networks derived from Breast Cancer Stem Cells control the immune response in the Basal subtype
- (2017) W. A. da Silveira et al. Scientific Reports
- miR-509-5p and miR-1243 increase the sensitivity to gemcitabine by inhibiting epithelial-mesenchymal transition in pancreatic cancer
- (2017) Hidekazu Hiramoto et al. Scientific Reports
- The relationship between platinum drug resistance and epithelial–mesenchymal transition
- (2016) Anamaria Brozovic ARCHIVES OF TOXICOLOGY
- Chemotherapy curable malignancies and cancer stem cells: a biological review and hypothesis
- (2016) Philip Savage BMC CANCER
- Use of retinoic acid/aldehyde dehydrogenase pathway as potential targeted therapy against cancer stem cells
- (2016) Jan S. Moreb et al. CANCER CHEMOTHERAPY AND PHARMACOLOGY
- Emerging Non-Canonical Functions and Regulation by p53: p53 and Stemness
- (2016) David Olivos et al. INTERNATIONAL JOURNAL OF MOLECULAR SCIENCES
- Eradication of CD44-variant positive population in head and neck tumors through controlled intracellular navigation of cisplatin-loaded nanomedicines
- (2016) Ming Wang et al. JOURNAL OF CONTROLLED RELEASE
- Activation of PKA leads to mesenchymal-to-epithelial transition and loss of tumor-initiating ability
- (2016) D. R. Pattabiraman et al. SCIENCE
- CD44 high CD24 low molecular signature determines the Cancer Stem Cell and EMT phenotype in Oral Squamous Cell Carcinoma
- (2016) Sangeeta Ghuwalewala et al. Stem Cell Research
- Concise Review: Stem Cells and Epithelial-Mesenchymal Transition in Cancer: Biological Implications and Therapeutic Targets
- (2016) Ryo Sato et al. STEM CELLS
- miR-204 regulates the EMT by targeting snai1 to suppress the invasion and migration of gastric cancer
- (2016) Zhe Liu et al. TUMOR BIOLOGY
- Dormant tumor cells expressing LOXL2 acquire a stem-like phenotype mediating their transition to proliferative growth
- (2016) Keren Weidenfeld et al. Oncotarget
- Targeting signal transduction pathways of cancer stem cells for therapeutic opportunities of metastasis
- (2016) Waqas Iqbal et al. Oncotarget
- Signal Transduction Pathways of EMT Induced by TGF-β, SHH, and WNT and Their Crosstalks
- (2016) Jingyu Zhang et al. Journal of Clinical Medicine
- Adoptive T-cell therapy of prostate cancer targeting the cancer stem cell antigen EpCAM
- (2015) Zhenling Deng et al. BMC IMMUNOLOGY
- The Cancer Stem Cell Niche: How Essential Is the Niche in Regulating Stemness of Tumor Cells?
- (2015) Vicki Plaks et al. Cell Stem Cell
- Epithelial-to-mesenchymal transition is not required for lung metastasis but contributes to chemoresistance
- (2015) Kari R. Fischer et al. NATURE
- Concise Review: Emerging Role of CD44 in Cancer Stem Cells: A Promising Biomarker and Therapeutic Target
- (2015) Yongmin Yan et al. Stem Cells Translational Medicine
- Regulated genes in mesenchymal stem cells and gastric cancer
- (2015) Shihori Tanabe World Journal of Stem Cells
- Origin of cells and network information
- (2015) Shihori Tanabe World Journal of Stem Cells
- Metformin: Multi-faceted protection against cancer
- (2015) Sonia Del Barco et al. Oncotarget
- Epithelial–mesenchymal transition-associated miRNAs in ovarian carcinoma, with highlight on the miR-200 family: Prognostic value and prospective role in ovarian cancer therapeutics
- (2014) Maria Koutsaki et al. CANCER LETTERS
- Gene expression signatures for identifying diffuse-type gastric cancer associated with epithelial-mesenchymal transition
- (2014) SHIHORI TANABE et al. INTERNATIONAL JOURNAL OF ONCOLOGY
- Progress of drug-loaded polymeric micelles into clinical studies
- (2014) Horacio Cabral et al. JOURNAL OF CONTROLLED RELEASE
- Phase I Study of GC1008 (Fresolimumab): A Human Anti-Transforming Growth Factor-Beta (TGFβ) Monoclonal Antibody in Patients with Advanced Malignant Melanoma or Renal Cell Carcinoma
- (2014) John C. Morris et al. PLoS One
- Identification of upstream regulators for prognostic expression signature genes in colorectal cancer
- (2013) Taejeong Bae et al. BMC Systems Biology
- Tumour heterogeneity and cancer cell plasticity
- (2013) Corbin E. Meacham et al. NATURE
- miR-655 Is an EMT-Suppressive MicroRNA Targeting ZEB1 and TGFBR2
- (2013) Yosuke Harazono et al. PLoS One
- MicroRNA control of epithelial–mesenchymal transition and metastasis
- (2012) Jinsong Zhang et al. CANCER AND METASTASIS REVIEWS
- Cancer Stem Cells: Impact, Heterogeneity, and Uncertainty
- (2012) Jeffrey A. Magee et al. CANCER CELL
- MicroRNA dysregulation in cancer: diagnostics, monitoring and therapeutics. A comprehensive review
- (2012) Marilena V. Iorio et al. EMBO Molecular Medicine
- Cancer Stem Cell Niche: The Place to Be
- (2011) T. Borovski et al. CANCER RESEARCH
- Transforming growth factor-beta 2 gene silencing with trabedersen (AP 12009) in pancreatic cancer
- (2011) Karl-Hermann Schlingensiepen et al. CANCER SCIENCE
- Inducible formation of breast cancer stem cells and their dynamic equilibrium with non-stem cancer cells via IL6 secretion
- (2011) D. Iliopoulos et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Transforming growth factor-β-induced epithelial–mesenchymal transition facilitates epidermal growth factor-dependent breast cancer progression
- (2010) M K Wendt et al. ONCOGENE
- Transforming growth factor β signaling inhibitor, SB-431542, induces maturation of dendritic cells and enhances anti-tumor activity
- (2010) Tanaka ONCOLOGY REPORTS
- Downregulated MicroRNA-200a in Meningiomas Promotes Tumor Growth by Reducing E-Cadherin and Activating the Wnt/ -Catenin Signaling Pathway
- (2009) O. Saydam et al. MOLECULAR AND CELLULAR BIOLOGY
- Messenger RNA regulation: to translate or to degrade
- (2008) Ann-Bin Shyu et al. EMBO JOURNAL
- LY2109761, a novel transforming growth factor receptor type I and type II dual inhibitor, as a therapeutic approach to suppressing pancreatic cancer metastasis
- (2008) D. Melisi et al. MOLECULAR CANCER THERAPEUTICS
- Direct regulation of TWIST by HIF-1α promotes metastasis
- (2008) Muh-Hwa Yang et al. NATURE CELL BIOLOGY
- The miR-200 family and miR-205 regulate epithelial to mesenchymal transition by targeting ZEB1 and SIP1
- (2008) Philip A. Gregory et al. NATURE CELL BIOLOGY
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started